Alternating Hemiplegia of Childhood mutations have a differential effect on Na+,K+-ATPase activity and ouabain binding

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 7, 2014, Pages 1010-1016

  Weigand, Karl M ^a   Messchaert, Muriël ^a   Swarts, Herman G P ^a   Russel, Frans G M ^a   Koenderink, Jan B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

AHC; Alpha 3; Alternating Hemiplegia of Childhood; ATP1A3

Indexed keywords

ADENOSINE TRIPHOSPHATASE; D 220 N PROTEIN; D 801 N PROTEIN; E 815 K PROTEIN; G 947 R PROTEIN; I 274 N PROTEIN; INSECT PROTEIN; OUABAIN; POTASSIUM ION; S 137 Y PROTEIN; SODIUM; UNCLASSIFIED DRUG;

ALTERNATING HEMIPLEGIA OF CHILDHOOD; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BINDING SITE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FUNCTIONAL DISEASE; HEMIPLEGIA; HUMAN; INSECT CELL; MUTANT; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE;

AHC; ALPHA 3; ALTERNATING HEMIPLEGIA OF CHILDHOOD; ATP1A3; NA(+),K(+)-ATPASE;

ANIMALS; CELL LINE; GENETIC PREDISPOSITION TO DISEASE; HEMIPLEGIA; HUMANS; MODELS, MOLECULAR; MUTATION; OUABAIN; PHENOTYPE; PHOSPHORYLATION; POTASSIUM; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SF9 CELLS; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPODOPTERA;

EID: 84897423363     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.03.002     Document Type: Article

References (36)

1. Verret S., Steele J.C. Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy. Pediatrics 1971, 47:675-680.
2. Neville B.G., Ninan M. The treatment and management of alternating hemiplegia of childhood. Dev. Med. Child Neurol. 2007, 49:777-780.
3. Bourgeois M., Aicardi J., Goutieres F. Alternating hemiplegia of childhood. J. Pediatr. 1993, 122:673-679.
4. Mikati M.A., Kramer U., Zupanc M.L., Shanahan R.J. Alternating hemiplegia of childhood: clinical manifestations and long-term outcome. Pediatr. Neurol. 2000, 23:134-141.
5. Sweney M.T., Silver K., Gerard-Blanluet M., Pedespan J.M., Renault F., Arzimanoglou A., et al. Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome. Pediatrics 2009, 123:e534-e541.
6. Casaer P., Azou M. Flunarizine in alternating hemiplegia in childhood. Lancet 1984, 2:579.
7. Silver K., Andermann F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology 1993, 43:36-41.
8. Heinzen E.L., Swoboda K.J., Hitomi Y., Gurrieri F., Nicole S., de Vries B., et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat. Genet. 2012, 44:1030-1034.
9. Rosewich H., Thiele H., Ohlenbusch A., Maschke U., Altmuller J., Frommolt P., et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol. 2012, 11:764-773.
10. Sasaki M., Ishii A., Saito Y., Morisada N., Iijima K., Takada S., et al. Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology 2014, 82:482-490.
11. +-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia Parkinsonism. Neuron 2004, 43:169-175.
12. +-ATPase alpha3 missense mutant mice. PLoS ONE 2013, 8:e60141.
13. Roubergue A., Roze E., Vuillaumier-Barrot S., Fontenille M.J., Meneret A., Vidailhet M., et al. The multiple faces of the ATP1A3-related dystonic movement disorder. Mov. Disord. 2013, 28:1457-1459.
14. Sasaki M., Ishii A., Saito Y., Hirose S. Intermediate form between alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism. Mov. Disord. 2014, 29:153-154.
15. +-ATPase: functions in the nervous system and involvement in neurologic disease. Neurology 2011, 76:287-293.
16. Kaplan J.H. Biochemistry of Na,K-ATPase. Ann. Rev. Biochem. 2002, 71:511-535.
17. +-ATPase ion pumps. Nat. Rev. Mol. Cell Biol. 2011, 12:60-70.
18. Luckow V.A., Lee S.C., Barry G.F., Olins P.O. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 1993, 67:4566-4579.
19. El-Sheikh A.A., van den Heuvel J.J., Krieger E., Russel F.G., Koenderink J.B. Functional role of arginine 375 in transmembrane helix 6 of multidrug resistance protein 4 (MRP4/ABCC4). Mol. Pharmacol. 2008, 74:964-971.
20. +, NH4(+)-ATPase. J. Biol. Chem. 2005, 280:33115-33122.
21. Koenderink J.B., Geibel S., Grabsch E., De Pont J.J., Bamberg E., Friedrich T. Electrophysiological analysis of the mutated Na,K-ATPase cation binding pocket. J. Biol. Chem. 2003, 278:51213-51222.
22. + affinity of these enzymes. J. Biol. Chem. 1999, 274:11604-11610.
23. +-ATPase play a key role in ouabain binding. J. Biol. Chem. 2003, 278:47240-47244.
24. +-bound state. Science 2013, 342:123-127.
25. 2+ bound in the cation binding site. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:10958-10963.
26. Shinoda T., Ogawa H., Cornelius F., Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4A resolution. Nature 2009, 459:446-450.
27. Ishii A., Saito Y., Mitsui J., Ishiura H., Yoshimura J., Arai H., et al. Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients. PLoS ONE 2013, 8:e56120.
28. Poulsen H., Khandelia H., Morth J.P., Bublitz M., Mouritsen O.G., Egebjerg J., Nissen P. Neurological disease mutations compromise a C-terminal ion pathway in the Na(+)/K(+)-ATPase. Nature 2010, 467:99-102.
29. Takeuchi A., Reyes N., Artigas P., Gadsby D.C. The ion pathway through the opened Na(+), K(+)-ATPase pump. Nature 2008, 456:413-416.
30. Koenderink J.B., Swarts H.G., Hermsen H.P., Willems P.H., De Pont J.J. Mutation of aspartate 804 of Na(+),K(+)-ATPase modifies the cation binding pocket and thereby generates a high Na(+)-ATPase activity. Biochemistry 2000, 39:9959-9966.
31. + coordinating residues in alpha-subunit of renal Na,K-ATPase. FEBS Lett. 1997, 400:206-210.
32. Morth J.P., Pedersen B.P., Toustrup-Jensen M.S., Sorensen T.L., Petersen J., Andersen J.P., Vilsen B., Nissen P. Crystal structure of the sodium-potassium pump. Nature 2007, 450:1043-1049.
33. 1P state. Nature 2013, 502:201-206.
34. Kuntzweiler T.A., Arguello J.M., Lingrel J.B. Asp804 and Asp808 in the transmembrane domain of the Na,K-ATPase alpha subunit are cation coordinating residues. J. Biol. Chem. 1996, 271:29682-29687.
35. Di Michele M., Goubau C., Waelkens E., Thys C., De Vos R., Overbergh L., et al. Functional studies and proteomics in platelets and fibroblasts reveal a lysosomal defect with increased cathepsin-dependent apoptosis in ATP1A3 defective alternating hemiplegia of childhood. J. Proteomics 2013, 86:53-69.
36. Bagrov A.Y., Shapiro J.I., Fedorova O.V. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 2009, 61:9-38.